Weight Loss
SEMAGLUTIDE WEIGHT LOSS PROGRAM
Women’s Weight Loss in Charleston, SC
PHYSICIAN-SUPERVISED WEIGHT LOSS
Our Women’s Weight Loss Semaglutide Program is designed to help busy adults make their weight management and health a priority. It is a physician-supervised program that combines Semaglutide peptide therapy, a balanced diet and Lipo B-12 injections.
A proven solution for stubborn weight loss.
ADDRESSING THE FOUR COMMON REASONS DIET OR WEIGHT LOSS PROGRAMS FAIL.
There are four common reasons diet or weight loss programs fail. Diets often leave you feeling constantly hungry and with a sense of fatigue/lack of energy. The daily battle to do it all AND still get healthy meals and exercise into our routine can be tough and this can wreak havoc on your health.
The Women’s Semaglutide Weight Loss at Rhett Women’s Center addresses these concerns by:
- Curbing appetite naturally with the prescribed Semaglutide peptides clinically proven to combat hunger and achieve results.
- Increasing metabolism and helping to optimize blood sugar, through Semaglutide peptide therapy.
- Physician oversight to ensure you reach your goals safely.
- Supplements and Lipo B-12 injections to improve energy and metabolism in conjunction with Semaglutide.
Benefits of Semaglutide
- Promotes Weight Loss
- Promotes inches lost in stubborn midriff area
- Reduced Appetite
- Improves HbA1C
- Improves PCOS Symptoms
- Lowers Inflammation
- Reduction in cardiovascular event Reduction in risk for patients with Diabetes
- Reduces Sugar Cravings
Dr. Rhett’s Tips to Succeed with Semaglutide Weight Loss Program
The cost is $300 a month for the first 2 months then increases to $350 thereafter as you slowly titrate up in medication. This is a cash product. We will not file insurance nor do a prior authorization. Minimum lab work is required. We will want to check metabolic profile at the start and then as indicated. Most patients will want to use it for four months, and if it’s successful, you may want to continue its use. You are required to make monthly visits with your provider.
This medicine will help with weight loss, but needs to be accompanied by a low starch, low sugar diet with some minimal exercise daily i.e., a 20-minute walk. Consumption of 3+ quarts of water daily. Over 16 weeks, a patient can expect to lose about 10% of their body fat. Using intermittent fasting is also very helpful in achieving weight loss with or without this medicine.
If you are interested, please talk to your doctor or the nursing staff. They will help you get started on this program.
A very simple way to think about dieting is to give up “S’s”:
Sugar, starch, snacks, sodas, and sugar substitute
Starches: wheat: bread, bagels, buns, biscuits, wraps, rolls, cereals, crackers, cookies, cakes, donuts, muffins, pancakes, and pasta.
Potatoes: sweet or regular fried potatoes, baked, chips, potato salad, potato pancakes, hashbrowns.
Rice: white rice, brown rice, red rice, yellow rice, rice crispies, rice cake, rice pudding.
Corn on the cob, off the cob, cornbread, hoecakes, popcorn, and grits.
Avoid grapes, bananas, and all melons
Sodas include sweet sodas, as well as diet sodas.
Snacks are anything that is not part of a meal.
Sugar substitutes are to be avoided.
Daily 20-minute walks.
Daily consumption of 3+ quarts of water.
A simple method of intermittent fasting:
Skip Breakfast 3 times a week, lunch twice a week, and supper once a week.
Our goal here at Rhett Women’s Center is to assist you in achieving your goal in your weight loss journey and healthy lifestyle.
Learn more about proven results of Semaglutide for women’s weight loss in our blog, Semaglutide: A Clinically Proven Treatment For Weight Loss In Women.
TIRZEPATIDE VS. SEMAGLUTIDE: WHAT IS THE DIFFERENCE
Tirzepatide and semaglutide are both available at Rhett Women’s Center. Tirzepatide is known frequently by the brand drug name Mounjaro®, and semaglutide is commonly known by the brand name Ozempic® or Wegovy ®. Rhett Women’s Center provides both options compounded with vitamin B-12. Both weight loss options can be very effective for weight loss.
WHAT IS TIRZEPATIDE?
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA). The FDA approved it in May of 2022 for treating type 2 diabetes. Rhett Women’s Center prescribes and monitors tirzepatide to promote weight loss among women.
WHAT IS SEMAGLUTIDE?
Known commonly as Ozempic® or Wegovy®, semaglutide is a glucagon-like peptide-1 receptor agonist, or GLP-1. The FDA approved semaglutide for the treatment of type 2 diabetes and obesity. Rhett Women’s Center prescribes and monitors semaglutide to promote weight loss among women.
COMPARING TIRZEPATIDE AND SEMAGLUTIDE
Both drugs improve metabolic health by reducing hemoglobin A1C (hbA1C) and assisting with weight loss. Early data supports that they may also reduce the likelihood of heart attack or stroke.
Once weekly tirzepatide and injectable semaglutide have different price points and dosages. Tirzepatide is a new, injectable medication administered subcutaneously once weekly with a recommended starting dosage of 2.5 mg. After four weeks, doses of tirzepatide may be increased in 2.5 mg increments up to a maximum of 15 mg once weekly.
Tirzepatide, while in the GLP-1 drug family, also contains a GIP receptor agonist. That means it works by stimulating the release of two unique hormones produced by the human body versus semaglutide’s one release.
GIP is a hormone that complements the effects of GLP-1 receptor agonists. The GIP component of tirzepatide further decreases food intake and increases energy expenditure, resulting in weight reduction somewhat better than the GLP-1 alone.
Whenever we eat food, hormones are released. That hormone release promotes a feeling of fullness by delaying gastric emptying and activating the satiety centers in the brain. They also help normalize blood sugar by boosting insulin production in the pancreas and suppressing glucagon production.
Tirzepatide and semaglutide help to lower the weight your body naturally settles at, which increases the likelihood you’ll be able to keep the weight off over time.
Patients with frequent weight fluctuations, those who have undergone bariatric surgery, and those who regained weight may have disrupted the body’s natural hormone release. Semaglutide and tirzepatide help re-regulate your body.
HOW DOES SEMAGLUTIDE WORK?
Semaglutide GLP-1 drugs work similarly to tirzepatide by mimicking the incretin hormones that your body naturally produces when you eat food. To clarify further, this means it regulates appetite and lowers blood glucose and A1C levels.
Semaglutide injection is a once-weekly medication in the GLP-1 receptor agonist class of drugs. Initially used in adults with type 2 diabetes to improve glucose and reduce the risk of cardiovascular disease, semaglutide is now also used to help women who have and do not have type 2 diabetes lose weight. It helps to release insulin, lowers the amount of glucose produced by the liver when glucose rises at mealtime, and slows the absorption of mealtime glucose.
Semaglutide has been studied for over five years and is proven safe and effective for those who are obese or overweight. It is a once-weekly subcutaneous injection and is available in doses that begin at 0.25 mg and titrate up to 2.0 mg.
While tirzepatide acts on GIP and GLP-1 receptors, semaglutide acts solely on GLP-1 receptors. Even so, this does not make semaglutide a lesser option for weight loss. How well semaglutide works for your body depends on many factors, ranging from your genetic profile and health history to your physical predispositions, lifestyle, and preferences.
For example, semaglutide may be easier for your body to tolerate and produce fewer side effects while helping you reach your weight loss goals. The same goes for dosage. Some individuals find that they need to titrate up to the maximum dose of a given GLP-1 drug reasonably quickly, while others make progress on a lower dose for an extended period.
Rhett Women’s Center’s physicians will help you determine the best medication based on your unique factors and goals. Please note that Rhett Women’s Center recommends that all patients on GLP-1 (semaglutide) or dual GIP/GLP-1 (tirzepatide) drugs should simultaneously make modifications to what food consumption, nutrition, frequency of exercise, and other healthy lifestyle choices.